Given that lymphangiogenesis is regulated by lymphatic vascular endothelial growth factors (VEGFs) binding to VEGFR-3, the stimulation of VEGFR-3 aggravated colitis, while the administration of VEGF-C alleviated colitis [17,18,19]. The gene discussed is FLT4; the disease is colitis.